C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Takes $2.28 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 32,968 shares of the company's stock, valued at approximately $2,281,000.

Several other large investors have also recently bought and sold shares of the stock. FMR LLC increased its stake in Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company's stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP increased its stake in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after buying an additional 600,000 shares during the period. Nuance Investments LLC boosted its position in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC boosted its position in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock valued at $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Henry Schein by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company's stock valued at $85,662,000 after purchasing an additional 6,184 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Down 1.0 %

Shares of HSIC stock traded down $0.81 during trading on Friday, hitting $77.24. 3,295,278 shares of the company were exchanged, compared to its average volume of 1,508,673. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market capitalization of $9.63 billion, a price-to-earnings ratio of 31.79, a P/E/G ratio of 2.12 and a beta of 0.91. The business's 50-day simple moving average is $74.13 and its 200 day simple moving average is $72.15. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on HSIC shares. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Barrington Research raised their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research report on Thursday, January 30th. Finally, Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective for the company. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and a consensus target price of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.